OLOncology Letters1792-10741792-1082D.A. Spandidos10.3892/ol.2018.8355OL-0-0-8355ReviewFunction of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseasesLiRuyi1ZhouRui1*ZhangJiange2*Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. ChinaInnovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. ChinaCorrespondence to: Dr Rui Zhou, Department of Respiratory Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong, Changsha, Hunan 410011, P.R. China, E-mail: zhourui2355@csu.edu.cn orDr Jiange Zhang, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 280 Huatuo Road, Pudong, Shanghai 201203, P.R. China, E-mail: jgzhang@shutcm.edu.cn
Previous research has identified that air pollution is associated with various respiratory diseases, but few studies have investigated the function served by particulate matter 2.5 (PM2.5) in these diseases. PM2.5 is known to cause epigenetic and microenvironmental alterations in lung cancer, including tumor-associated signaling pathway activation mediated by microRNA dysregulation, DNA methylation, and increased levels of cytokines and inflammatory cells. Autophagy and apoptosis of tumor cells may also be detected in lung cancer associated with PM2.5 exposure. A number of mechanisms are involved in triggering and aggravating asthma and COPD, including PM2.5-induced cytokine release and oxidative stress. The present review is an overview of the underlying molecular mechanisms of PM2.5-induced pathogenesis in lung cancer and chronic airway inflammatory diseases.
Previous studies have identified a marked association between particulate matter 2.5 (PM2.5) exposure and increased incidence of pulmonary diseases (1). PM2.5 is a type of air pollutant with a diameter of ≤2.5 µm, characterized by its small particle size (2), large surface area and toxin absorption ability (3). These properties make it possible for PM2.5 to invade the smallest airways, including alveolar tissue. PM2.5 comprises a mixture of solid and liquid particles, including black carbon, metals, nitrate, sulfate, polycyclic aromatic hydrocarbons and automobile exhaust particles (4). It has been demonstrated that exposing mice to PM2.5 led to easier deposition of PM2.5 into lung issues compared with other metal pollutants (5). Numerous biological activities, including cytokine formation, coagulation balance, and cardiac and pulmonary function have been demonstrated to be altered by PM2.5 (6).
It has also been indicated that PM2.5 may trigger asthma, chronic obstructive lung disease (COPD) and lung cancer through the activation of various signaling pathways, including AMP-activated protein kinase (AMPK) catalytic subunit α1 and signal transducer and activator of transcription (STAT)-1 (7). It has also been suggested that vascular endothelial growth factor receptor (VEGF), mitogen-activated protein kinase (MAPK), nuclear factor κB (NF-κB) and interleukin (IL)-8 signaling is involved in PM2.5-induced lung injury (8). In PM2.5-exposed rats, a decrease in phosphatidylcholine levels may be detected, which may impair alveolar type II cells and alter cell functions (9). In addition, PM2.5 exposure has been demonstrated to be associated with endothelial cell apoptosis and systemic inflammation (10). Numerous studies have suggested that lung function impairment in mice may also be induced by PM2.5 (6), and that the transforming growth factor-β/Smad signaling pathway may participate in this process (11). A European cohort study indicated that PM2.5 exposure increased the risk of lung cancer, particularly lung adenocarcinoma (12). Another study demonstrated that if the daily average concentration of PM2.5 was decreased to 10 µg/m3, 90% of children with respiratory diseases would be admitted to hospital less frequently (13). Furthermore, each 10-µg/m3 increase in PM2.5 was indicated to cause a 0.23% increase in total emergency room visits due to respiratory diseases, of which the majority of patients exhibited acute exacerbation of COPD (AECOPD). The rate of respiratory infection has also been demonstrated to increase with increased PM2.5 levels (14). Similar results were obtained in terms of hospital admissions of respiratory diseases and PM2.5 levels in Taiwan (15). Furthermore, it has been revealed that the mortality rates of emphysema, asthma and pneumonia are significantly associated with particulate polluting matter (16). PM2.5 has also been positively associated with the number of outpatient visits for acute respiratory diseases, including acute bronchitis (17).
PM2.5 has an adverse impact on cardiovascular, respiratory and endocrine systems
A considerable number of epidemiological studies have demonstrated that long-term exposure to PM2.5 may cause damage to the cardiovascular, respiratory and endocrine systems (18,19). It has been indicated that PM2.5 exposure is associated with a notable proportion of mortalities due to numerous diseases, including lung cancer (23.9%), COPD (18.7%), stroke (40.3%) and ischemic heart disease (IHD) (26.8%) (20). It was reported that each 10-µg/m3 increase in acute PM2.5 exposure in the northeastern USA resulted in a 0.26% increase in the number of admissions of patients with peripheral artery disease (21). Similarly, in Beijing (China), PM2.5 was significantly associated with the number of hospital emergency room visits for cardiovascular diseases, particularly IHD, heart arrhythmia and atrial fibrillation (22). PM2.5 exposure together with cigarette smoking has been demonstrated to have an even greater impact on cardiovascular disease-associated mortality (23). A meta-analysis study indicated that ambient PM2.5 exposure was associated with a high risk of atrial fibrillation (24). However, it has been reported that lung cancer and cardiovascular diseases respond differently to PM2.5 exposure (25).
In terms of endocrine function, it has been suggested that early-life PM2.5 exposure may serve a pivotal effect in childhood overweight or obesity (26). Another study detected impairment of adult renal function in the Taipei metropolis following exposure to PM10, but not PM2.5 (27).
PM2.5-induced pathogenesis varies in lung cancerEpidemiological studies of lung cancer
Researchers have identified lung cancer as one of the most significant causes of cancer-associated mortality, and non-small cell lung cancer (NSCLC) has been reported to account for 80% lung cancer (28). NSCLC has a low 5-year survival rate (29). Previous epidemiological studies have indicated that ambient PM2.5 is carcinogenic (30), and may increase the morbidity and mortality rates associated with lung cancer (31,32), and PM2.5 has been suggested to decrease the survival time of patients with lung cancer (33). A short-term decrease in PM2.5 exposure has been demonstrated to decrease the population risk of lung cancer (34).
Oncogene activation, mediated by microRNAs (miRs), involved in PM2.5-induced lung cancer
miRs are a class of small non-coding single-stranded RNA molecules which participate in the regulation of post-transcriptional gene expression and RNA silencing (35). It has been established that miRs regulate 50% of protein-coding genes and cell metabolic processes (36). However, the pathogenesis of PM2.5 induction of lung cancer remains to be elucidated. A previous study indicated that exposing human bronchial epithelial (HBE) cells to ambient PM2.5 resulted in downregulation of miR-182 and miR-185 expression compared with non-exposed cells (37). The expression of three target oncogenes, solute carrier family 30 member 1, serpin family B member 2 and aldo-keto reductase family 1 member C1, which are markedly expressed in human lung adenocarcinoma cells and squamous carcinoma cells, may cause neoplastic transformation in NIH3T3 cells (37). However, whether this is translatable to humans remains unknown. Another study investigated the association between PM2.5 exposure and the miR-802/Rho family GTPase 3 (Rnd3) pathway in lung cancer in vivo and in vitro. PM2.5 was demonstrated to enhance the growth and metastasis of lung cancer (38). These results warrant further investigation of PM2.5-induced miR changes in lung cancer.
PM2.5-induced gene mutations have been investigated extensively
In one study, following exposure of HBE cells to 200 and 500 µg/ml PM2.5, 970 and 492 gene alterations were detected, respectively (39). Furthermore, an in vivo study demonstrated that, in PM2.5-treated mice, 57 genes were demonstrated to be mutated, including 14 upregulated genes and 43 downregulated genes (40). It has been suggested that these mutations occur in response to an exogenous stimulus, metabolic processing and an inflammatory immune pathway, possibly involving the MAPK signaling pathway (41). These studies provide a preliminary basis to direct further investigation of the function of miRs in oncogene activation in lung cancer following PM2.5 exposure. Furthermore, the interaction between PM2.5-induced long non-coding RNA (lncRNA) alteration and lung cancer has been studied, indicating that PM2.5 is able to induce lncRNA loc146880 via reactive oxygen species (ROS), promoting autophagy and malignancy of lung cancer cells (42).
PM2.5-induced tumor suppressor gene inactivation through DNA methylation
p53 is an important regulatory gene in cell proliferation, apoptosis and damage repair (43). Mutation of p53 contributes to the pathogenesis of lung cancer (44,45). A previous study sought to identify PM2.5-induced p53 mutations using human alveolar epithelial BEAS-2B cells constantly exposed to low-dose PM2.5 for 10 days. It was demonstrated that PM2.5 was able to trigger p53 promoter methylation by increasing DNA (cytosine-5-)-methyltransferase 3β (DNMT3B) methylation levels, resulting in p53 inactivation. The same study indicated that the ROS/protein kinase B (Akt) signaling pathway was involved in the process of DNMT3B methylation (46). Notably, these cells were exposed long term to ‘safe’ concentrations of PM2.5 (120 µg/m3). Furthermore, a previous study established that the expression of DNMT was different when cells were acutely exposed to high-dose PM2.5 (data not shown) (46). To the best of our knowledge, inactivation of other PM2.5-induced tumor suppressor genes via DNA methylation has not been demonstrated. However, a recent analysis of the methylome and transcriptome of PM2.5-induced (100 µg/ml) BEAS-2B cells identified 66 differentially expressed genes, which were either hyper- or hypo-methylated, involved in lung diseases, particularly lung cancer (47). A number of the genes were identified to be involved in tumor suppression, including deleted in malignant brain tumors 1, ERBB receptor feedback inhibitor 1 and gap junction protein β2. Another study observed gene methylation in healthy mice exposed to traffic-associated air pollution, including upregulation of p16 and adenomatous polyposis coli methylation, and downregulation of long interspersed nuclear element-1 and nitric oxide synthase 2 methylation (48). It has been demonstrated that following exposure to PM2.5, DNA methylation of tandem repeats increases (49). A tandem repeat (NBL2) methylation has been identified to be associated with PM2.5 silicon in truck drivers, and another tandem repeat (SATα) methylation has been associated with sulfur exposure in office workers (50), which may lead to an increase in the risk of lung cancer. These studies provide a basis for further investigation of the association between PM2.5-induced tumor suppressor gene methylation and lung cancer.
PM2.5-induced microenvironment alteration in lung cancer
The tumor microenvironment is of importance to tumor behavior, particularly in lung cancer (51). The production of cytokines, inflammatory cells and angiogenesis has been identified to be associated with tumor metastasis and tumor cell proliferation (52). Numerous inflammatory cytokines and transcription factors function in the lung cancer tumor microenvironment, including interleukin (IL)-1β and −6, tumor necrosis factor α (TNF-α), NF-κB and STAT-3 (53). PM2.5 exposure is able to increase the mobility and proliferation of A549 and H1299 cells, and IL-1β and MMP-1 may be responsible for the effects of PM2.5 (54). It has also been suggested that alveolar macrophage polarization may serve a function in angiogenesis and tumor growth via secretion of IL-8 and VEGF (55). Previous studies have demonstrated that PM2.5 is able to induce HBE cells and macrophages to release various pro-inflammatory cytokines, including IL-6, TNF-α and granulocyte-macrophage colony stimulating factor (GM-CSF), resulting in airway inflammation (41,56,57). Therefore, by triggering angiogenesis and inflammatory reactions, PM2.5-induced tumor microenvironment alteration may promote tumor growth and metastasis.
PM2.5-induced autophagy and apoptosis
Autophagy refers to the encapsulation of damaged proteins or organelles of eukaryotic cells by autophagic vesicles, followed by lysosomal degradation and recycling (58). Autophagy serves an important function in emergent cell processes, including starvation and infection (59). As a self-destructive activity, apoptosis serves an essential function in tissue homeostasis, embryonic development and organogenesis (60). Crosstalk between autophagic and apoptotic pathways have been characterized in cell fate decision making (61,62). Caspases, a group of cysteine proteases, are best known as apoptosis modulators, and function in the crosstalk between autophagy and apoptosis (63). Crucial autophagy proteins, including Beclin-1 and autophagy-related 5 may be degraded by activated caspases to attenuate the autophagic response (64,65). Furthermore, autophagy is able to regulate apoptosis by altering the level and activity of caspase proteins (66). PM2.5 exposure may induce macrophage autophagy and mediate the Src/STAT-3 signaling pathway to increase the expression of VEGF-A, an important pro-angiogenic factor (67). It has also been suggested that the phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin kinase signaling pathway may serve an important function in the autophagy of BEAS-2B cells exposed to PM2.5 (68). PM2.5 is able to induce autophagy of A549 cells by activating the AMPK signaling pathway (69). Autophagy serves as a protective mechanism, thus preventing further damage by PM2.5 (70).
PM2.5 induces inflammatory cell infiltration and alveolar cell autophagy, and also alters the cell cycle of alveolar epithelial cells and induces cell apoptosis. A number of studies have demonstrated that PM2.5 is able to induce mitotic arrest by breaking DNA double strands and activating the p53/retinoblastoma signaling pathway (71–73). PM2.5 has also been demonstrated to activate the TNF-α signaling pathway and manipulate the transcription of p53, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein, resulting in apoptosis of alveolar epithelial cells (74,75).
PM2.5-induced pathogenesis varies in chronic airway inflammatory diseasesEpidemiological investigation of chronic airway inflammatory diseases
The most common chronic airway inflammatory diseases are asthma and COPD (76). Asthma is characterized by chronic pulmonary inflammation and airway hyper-responsiveness (77). It has been demonstrated that asthma is associated with numerous environmental and genetic factors (78). Epidemiological evidence suggests that air pollution, including ambient PM2.5, may increase the morbidity and hospitalization rate of patients with asthma (79–81). Furthermore, air pollution has become an independent risk factor of asthma (82). Increased PM10 exposure has been identified to be associated with poor control of asthma and poor health-associated quality of life (83). The airway inflammation and immune response in the pathogenesis of asthma have been identified to be associated with the chemical composition and size distribution of PM2.5 (84). It has been identified that with increased levels of the heavy metal lead in PM2.5 in e-waste recycling areas, the level of lead in pediatric blood samples also increased (85). This is a cause for concern since asthma may be induced when blood lead content >5 µg/dl (85).
COPD is a type of obstructive lung disease characterized by long-term poor airflow, which typically worsens over time (86). Numerous studies have demonstrated that AECOPD is associated with air pollution, particularly PM2.5 (87). Each additional 10 µg/m3 PM2.5 exposure has been demonstrated to increase the rate of coughing symptoms by 33% and expectoration symptoms by 23%, and to decrease the diurnal variation rate of peak expiratory flow in patients with COPD (88). Long-term exposure to PM2.5 has been demonstrated to decrease the population forced expiratory volume in 1 sec and the forced vital capacity, accelerating the decline in lung function in healthy adults in a population-based cohort (89). Therefore, preventive medication is required to avoid exacerbation of COPD following exposure to PM2.5 (90).
PM2.5-induced inflammatory response and oxidative stress
Oxidative stress is able to modulate critical signal transduction pathways, including NF-κB signaling, and histone modifications; alterations which are crucial in lung inflammation (91). PM2.5 has been demonstrated to increase the expression of inflammatory cytokine receptors, which are able to activate IL-1 receptor (IL-1R)- and IL-6R-mediated signaling pathways in cells of the lung (92). In a previous study, short-term exposure of PM2.5 to mice induced inflammatory cell infiltration and lung tissue congestion, increasing the expression of inflammatory mediators, including TNF-α, IL-6 and IL-1β, and oncogenes, including c-Fos and c-Jun, which dysregulated a variety of metabolic enzyme activities, including superoxide dismutase and nitric oxide synthase (93). It has been reported that lung oxidative stress and inflammation may be induced by a low dose of PM2.5 in healthy mice (94).
PM2.5 has been demonstrated to increase the level of NF-E2-related factor 2 (Nrf2) expression in mice with COPD, and Nrf2 was associated with oxidative stress (95). PM2.5 exposure was observed to increase the expression of IL-8 in vitro, which was mediated by oxidative stress and endocytosis (96). The enhanced expression of TNF-α and IL-6 has also been detected in sub-chronic (PM2.5 tracheal instillation once a week for 1, 3 or 6 months) PM2.5-exposed mice with COPD, and it is known that cytokine overexpression is able to aggravate immune system damage (97).
Sub-chronic exposure to PM2.5 has also been indicated to induce inflammatory injury in rats and impair the phagocytic function of AM (alveolar macrophage) (98). Furthermore, PM2.5 has been demonstrated to increase the phagocytic ability of macrophages in mice with COPD, thus increasing oxidative stress (99). PM2.5 also impairs the immune balance of mice with COPD by blocking the Notch signaling pathway (99). Exposing nasal mucosa epithelial cells to PM2.5 indicated that PM2.5 was able to increase ROS and Nrf2 levels, which have an association with oxidative stress (100). This study also revealed that PM2.5 increased the release of GM-CSF, TNF-α and IL-13, accelerating the inflammatory reaction. Previous research has revealed that the process of inflammation and oxidative stress occur via different pathways (101), and different PM sources may result in different ROS viabilities (102). In order to explore the function of PM2.5 in the pathogenesis of asthma, one research group exposed asthmatic mice to PM2.5, revealing that the content of IL-4 and IL-10, mediated by TNF-α and T helper 2 cells, increased, coupled with the decreased content of INF-γ mediated by T helper 1 cells. Inflammatory infiltration and goblet cell metaplasia were also demonstrated to be accelerated following PM2.5 exposure (103). The acute inflammatory response following PM2.5 exposure has been revealed to involve TLR2 and TLR4, and a T helper 2 cell-mediated immune response was also detected (104). Furthermore, PM was demonstrated to induce T helper 1/2 cell inflammatory responses in healthy mice and may contribute to the initial onset of asthma (105).
PM2.5-induced pathogenesis in lung tuberculosis
Tuberculosis is a common chronic infectious disease caused by Mycobacterium tuberculosis, which is able to invade multiple organs, including the lungs (106). However, few studies have investigated the association between PM2.5 and pulmonary tuberculosis. It has been demonstrated that PM2.5 exposure in factory environments and smear-positive tuberculosis are associated; however, PM2.5 exposure in highway environments and smear-positive tuberculosis were not associated (107). PM2.5 exposure has been suggested to decrease the expression of hemoglobin subunit d2 and 3 in type II alveolar epithelial cells, increasing the risk of M. tuberculosis proliferation (108).
PM2.5-induced pathogenesis in respiratory infection
Respiratory infection may be characterized into upper and lower respiratory tract infections (109). It has been revealed that air pollution PM may alter anti-mycobacterial respiratory epithelium innate immunity systems (110). A European cohort study demonstrated that early childhood pneumonia was associated with air pollutants (111). Another study suggested that organic compounds in PM2.5 are able to aggravate the infection of upper and lower respiratory tract infections in children (112). It has also been indicated that the DNA repair gene xeroderma pigmentosum complementation group C may serve an essential function in the pathogenesis of PM2.5-induced bronchitis (113). To the best of our knowledge, the effect of PM2.5 in respiratory infection has not been demonstrated.
Conclusions
From the present review, the following conclusions can be inferred. The chemical properties and pathological toxicity of PM2.5 are known to influence a variety of respiratory diseases. Previous research has focused on the epidemiology and toxicology of PM2.5; however, more recent research has investigated the function that PM2.5 serves in the pathogenesis of respiratory diseases. PM2.5-induced epigenetic changes, including microRNA dysregulation (37) and DNA methylation (46), microenvironment alteration (53), cell autophagy and apoptosis (67,68), may result in oncogene activation and tumor suppressor gene inactivation in lung cancer (Fig. 1). By activating inflammatory-associated cells (93), including T helper 2 cells, and triggering oxidative stress (97), PM2.5 may induce and aggravate asthma and COPD (Fig. 2). PM2.5-induced alteration of molecular mechanisms in pulmonary tuberculosis and respiratory infection remain unclear. Furthermore, the properties of PM2.5 often vary with environmental changes, and further clarification is required.
Investigating the impact of PM2.5 on respiratory disease is essential, since numerous populations are currently experiencing heavy pollution. Understanding the molecular mechanisms of PM2.5-induced respiratory diseases may contribute to the development of targeted drugs and preventive treatments.
Acknowledgements
Not applicable.
Funding
The present study was supported by the National Key Clinical Specialty Construction Projects of China and National Natural Science Foundation of China (grant no. 81573579).
Availability of data and materials
Not applicable.
Authors' contributions
RL was responsible for the acquisition, analysis and summarizing of data, drafting the manuscript and revising it. RZ was involved in analyzing and interpreting the manuscript, and giving final approval of the version to be published. JZ has made substantial contributions to the conception and design of the present study. RZ and JZ are accountable for all aspects of the work.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
AbbreviationsAECOPD
acute exacerbation of chronic obstructive lung disease
COPD
chronic obstructive lung disease
DNMT3B
DNA (cytosine-5-)-methyltransferase 3β
HBE
human bronchial epithelial
IHD
ischemic heart disease
NSCLC
non-small cell lung cancer
ReferencesLiPXinJWangYWangSLiGPanXLiuZWangLThe acute effects of fine particles on respiratory mortality and morbidity in Beijing, 2004–20092064336444201310.1007/s11356-013-1688-823589266DuPDuRRenWLuZFuPSeasonal variation characteristic of inhalable microbial communities in PM2.5 in Beijing city, China610–611308315201810.1016/j.scitotenv.2017.07.097KimYSeoJKimJYLeeJYKimHKimBMCharacterization of PM2.5 and identification of transported secondary and biomass burning contribution in Seoul, Korea2543304343201810.1007/s11356-017-0772-x29181753BellMLDominiciFEbisuKZegerSLSametJMSpatial and Temporal Variation in PM2.5 Chemical Composition in the United States for Health Effects Studies115989995200710.1289/ehp.962117637911LiQLiuHAlattarMJiangSHanJMaYJiangCThe preferential accumulation of heavy metals in different tissues following frequent respiratory exposure to PM2.5 in rats516936201510.1038/srep1693626582271JiangSBoLDuXLiuJZengXHeGSunQKanHSongWXieYZhaoJCARD9-mediated ambient PM 2.5-induced pulmonary injury is associated with Th17 cell2733643201710.1016/j.toxlet.2017.03.01528315386Falcon-RodriguezCIOsornio-VargasARSada-OvalleISegura-MedinaPAeroparticles, composition, and lung diseases73201610.3389/fimmu.2016.0000326834745JeongSCChoYSongMKLeeERyuJCEpidermal growth factor receptor (EGFR)-MAPK-nuclear factor(NF)-κB-IL8: A possible mechanism of particulate matter(PM) 2.5-induced lung toxicity3216281636201710.1002/tox.2239028101945ChenWLLinCYYanYHChengKTChengTJAlterations in rat pulmonary phosphatidylcholines after chronic exposure to ambient fine particulate matter1031633169201410.1039/C4MB00435C25236678PopeCAIIIBhatnagarAMccrackenJPAbplanalpWConklinDJO'TooleTExposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation1191204201610.1161/CIRCRESAHA.116.30927927780829GuLZSunHChenJHHistone deacetylases 3 deletion restrains PM2.5-induced mice lung injury by regulating NF-κB and TGF-β/Smad2/3 signaling pathways85756762201710.1016/j.biopha.2016.11.09427919737Raaschou-NielsenOAndersenZJBeelenRSamoliEStafoggiaMWeinmayrGHoffmannBFischerPNieuwenhuijsenMJBrunekreefBAir pollution and lung cancer incidence in 17 European cohorts: Prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)14813822201310.1016/S1470-2045(13)70279-123849838de P Pablo-RomeroMRománRLimónJMPraena-CrespoMEffects of fine particles on children's hospital admissions for respiratory health in Seville, Spain65436444201510.1080/10962247.2014.1001499XuQWangSGuoYWangCHuangFLiXGaoQWuLTaoLGuoJAcute exposure to fine particulate matter and cardiovascular hospital emergency room visits in Beijing, China220317327201710.1016/j.envpol.2016.09.06527697383TsaiSSChiuHFLiouSHYangCYShort-term effects of fine particulate air pollution on hospital admissions for respiratory diseases: A case-crossover study in a tropical city7710911101201410.1080/15287394.2014.88124725072896KravchenkoJAkushevichIAbernethyAPRossWGJrLyerlyHKLong-term dynamics of death rates of emphysema, asthma, and pneumonia and improving air quality9613627201410.2147/COPD.S5999525018627LiRJiangNLiuQHuangJGuoXLiuFGaoZImpact of air pollutants on outpatient visits for acute respiratory outcomes14pii:E47201710.3390/ijerph14010047LinHWangXLiuTLiXXiaoJZengWMaWAir Pollution and Mortality in China1017103121201710.1007/978-981-10-5657-4_529177960VahedianMKhanjaniNMirzaeeMKoolivandAAmbient air pollution and daily hospital admissions for cardiovascular diseases in Arak, Iran13117134201729147121SongCHeJWuLJinTChenXLiRRenPZhangLMaoHHealth burden attributable to ambient PM2.5 in China223575586201710.1016/j.envpol.2017.01.06028169071KloogIFine particulate matter (PM2.5) association with peripheral artery disease admissions in northeastern United States26572577201610.1080/09603123.2016.121731527666297QinXXiaLWangSChaoWHuangFQiGWuLTaoLJinGWeiWFine particulate air pollution and hospital emergency room visits for respiratory disease in Urban areas in Beijing, China, in 201311e0153099201610.1371/journal.pone.015309927054582TurnerMCCohenABurnettRTJerrettMDiverWRGapsturSMKrewskiDSametJMPopeCAIIIInteractions between cigarette smoking and ambient PM2.5 for cardiovascular mortality154304310201710.1016/j.envres.2017.01.02428142053ShaoQLiuTKorantzopoulosPZhangZZhaoJLiGAssociation between air pollution and development of atrial fibrillation: A meta-analysis of observational studies45557562201610.1016/j.hrtlng.2016.08.00127590407PopeCAIIIBurnettRTTurnerMCCohenAKrewskiDJerrettMGapsturSMThunMJLung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: Shape of the exposure-response relationships11916161621201110.1289/ehp.110363921768054MaoGNachmanRMSunQZhangXKoehlerKChenZHongXWangGCarusoDZongGIndividual and Joint Effects of Early-Life Ambient PM2.5 Exposure and Maternal Pre-Pregnancy Obesity on Childhood Overweight or Obesity201610.1289/EHP26127120296YangYRChenYMChenSYChanCCAssociations between long-term particulate matter exposure and adult renal function in the taipei metropolis125602607201727713105RamalingamSPawlishKGadgeelSDemersRKalemkerianGPLung cancer in young patients: Analysis of a Surveillance, Epidemiology, and End Results database16651657199810.1200/JCO.1998.16.2.6519469354WangNLiangHZhouYWangCZhangSPanYWangYYanXZhangJZhangCYmiR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC9e105570201410.1371/journal.pone.010557025140799HarrisonRMSmithDJKibbleAJWhat Is Responsible for the Carcinogenicity of PM2.5?61799805200410.1136/oem.2003.01050415377764LiJLiWXBaiCSongYParticulate matter-induced epigenetic changes and lung cancer11539546201710.1111/crj.1238926403658Vinikoor-ImlerLCAllenDJLubenTJAn ecologic analysis of county-level PM2.5 concentrations and lung cancer incidence and mortality818651671201110.3390/ijerph806186521776206EckelSPCockburnMShuYHDengHLurmannFWLiuLGillilandFDAir pollution affects lung cancer survival71891898201610.1136/thoraxjnl-2015-20792727491839XieYZhaoBZhaoYLuoQWangSZhaoBBaiSReduction in population exposure to PM2.5 and cancer risk due to PM2.5-bound PAHs exposure in Beijing, China during the APEC meeting225338345201710.1016/j.envpol.2017.02.05928284555FabianMRSonenbergNFilipowiczWRegulation of mRNA translation and stability by microRNAs79351379201010.1146/annurev-biochem-060308-10310320533884PapoutsidakisNDeftereosSKaoukisABourasGGiannopoulosGTheodorakisAAngelidisCHatzisGStefanadisCMicroRNAs and the heart: Small things do matter13216230201310.2174/156802661131302000923470079LiuCGuoHChengXShaoMWuCWangSLiHWeiLGaoYTanWExposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells62942829439201526338969LiXLvYGaoNSunHLuRYangHZhangCMengQWuSLiAQmicroRNA-802/Rnd3 pathway imposes on carcinogenesis and metastasis of fine particulate matter exposure73502635043201627144337DingXWangMChuHChuMNaTWenYWuDHanBBaiZChenWGlobal gene expression profiling of human bronchial epithelial cells exposed to airborne fine particulate matter collected from Wuhan, China2282533201410.1016/j.toxlet.2014.04.01024769257SanciniGFarinaFBattagliaCCifolaIManganoEManteccaPCamatiniMPalestiniPHealth risk assessment for air pollutants: Alterations in lung and cardiac gene expression in mice exposed to Milano winter fine particulate matter (PM2.5)9e109685201410.1371/journal.pone.010968525296036ZhouZLiuYDuanFQinMWuFShengWYangLLiuJHeKTranscriptomic analyses of the biological effects of airborne PM2.5 exposure on human bronchial epithelial cells10e0138267201510.1371/journal.pone.013826726382838DengXFengNZhengMYeXLinHYuXGanZFangZZhangHGaoMPM 2.5 exposure-induced autophagy is mediated by lncRNA loc146880 which also promotes the migration and invasion of lung cancer cells1861112125201710.1016/j.bbagen.2016.11.00927836757CaiWLiQYangZMiaoXWenYHuangSOuyangJExpression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance15818824201310.1007/s12094-013-1010-823475628EllisPLonningPEBorresen-DaleAAasTGeislerSAkslenLASalterISmithIEDowsettMAbsence of p21 expression is associated with abnormal p53 in human breast carcinomas76480485199710.1038/bjc.1997.4139275025DebenCVan den BosscheJVan Der SteenNLardonFWoutersAde BeeckKOHermansCJacobsJPeetersMVan CampGDeep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants391010428317694327201710.1177/101042831769432728240049ZhouWTianDHeJWangYZhangLCuiLJiaLZhangLLiLShuYRepeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation72069120703201626942697HeßelbachKKimGJFlemmingSHäuplTBoninMDornhofRGüntherSMerfortIHumarMDisease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion12779792201710.1080/15592294.2017.135655528742980DingRJinYLiuXZhuZZhangYWangTXuYCharacteristics of DNA methylation changes induced by traffic-related air pollution7964653201610.1016/j.mrgentox.2015.12.00226778509GuoLByunHMZhongJMottaVBarupalJZhengYDouCZhangFMccrackenJPDiazAEffects of short-term exposure to inhalable particulate matter on DNA methylation of tandem repeats55322335201410.1002/em.2183824436168HouLZhangXZhengYWangSDouCGuoLByunHMMottaVMccrackenJDíazAAltered methylation in tandem repeat element and elemental component levels in inhalable air particles55256265201410.1002/em.2182924273195GravesEEMaityALeQTThe tumor microenvironment in non-small cell lung cancer20156163201010.1016/j.semradonc.2010.01.00320685578Vendramini-CostaDBCarvalhoJEMolecular link mechanisms between inflammation and cancer183831201210.2174/13816121280208370722632748ChoWCKwanCKYauSSoPPPoonPCAuJSThe role of inflammation in the pathogenesis of lung cancer1511271237201110.1517/14728222.2011.59980121751938YangBChenDHuiZXiaoCThe effects for PM2.5 exposure on non-small-cell lung cancer induced motility and proliferation52059201610.1186/s40064-016-3734-827995036AlmatroodiSAMcDonaldCFPouniotisDSAlveolar macrophage polarisation in lung cancer2014721087201410.1155/2014/72108726316944BauligABlanchetSRumelhardMLacroixGMaranoFBaeza-SquibanAFine urban atmospheric particulate matter modulates inflammatory gene and protein expression in human bronchial epithelial cells12771782200710.2741/210017127337GualtieriMManteccaPCettaFCamatiniMOrganic compounds in tire particle induce reactive oxygen species and heat-shock proteins in the human alveolar cell line A54934437442200810.1016/j.envint.2007.09.01017976723JiangMWeiQDongGKomatsuMSuYDongZAutophagy in proximal tubules protects against acute kidney injury8212711283201210.1038/ki.2012.26122854643ViryEPaggettiJBaginskaJMgrditchianTBerchemGMoussayEJanjiBAutophagy: An adaptive metabolic response to stress shaping the antitumor immunity923142201410.1016/j.bcp.2014.07.00625044308TaylorRCullenSMartinSApoptosis: Controlled demolition at the cellular level9231241200810.1038/nrm231218073771KimREmiMTanabeKRole of mitochondria as the gardens of cell death57545553200610.1007/s00280-005-0111-716175394MohseniNMcMillanSChaudharyRMokJReedBAutophagy promotes caspase-dependent cell death during Drosophila development5329338200910.4161/auto.5.3.744419066463JoubertPEWernekeSWde la CalleCGuivel-BenhassineFGiodiniAPedutoLLevineBSchwartzOLenschowDJAlbertMLChikungunya virus-induced autophagy delays caspase-dependent cell death20910291047201210.1084/jem.2011099622508836YouMSavarajNKuoMTWangpaichitrMVarona-SantosJWuCNguyenDMFeunLTRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation374181190201310.1007/s11010-012-1518-123180246ChoDJoYHwangJJLeeYMRohSAKimJCCaspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells27495100200910.1016/j.canlet.2008.09.00418842334HouWHanJLuCGoldsteinLARabinowichHAutophagic degradation of active caspase-8: A crosstalk mechanism between autophagy and apoptosis6891900201010.4161/auto.6.7.1303820724831XuXWangHLiuSXingCLiuYAodengqimugeZhouWYuanXMaYHuMTP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5)121832201610.1080/15548627.2016.120449627463284LiuTWuBWangYHeHLinZTanJYangLKampDWZhouXTangJParticulate matter 2.5 induces autophagy via inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin kinase signaling pathway in human bronchial epithelial cells1219141922201510.3892/mmr.2015.3577WangYLinZHuangHHeHYangLChenTYangTRenNJiangYXuWAMPK is required for PM2.5-induced autophagy in human lung epithelial A549 cells85872201525784975ZhouZShaoTQinMMiaoXChangYShengWWuFYuYThe effects of autophagy on vascular endothelial cells induced by airborne PM2.52017(In Press)LonghinEHolmeJAGutzkowKBArltVMKucabJECamatiniMGualtieriMCell cycle alterations induced by urban PM2.5 in bronchial epithelial cells: Characterization of the process and possible mechanisms involved1063201310.1186/1743-8977-10-6324354623GualtieriMOvrevikJMollerupSAsareNLonghinEDahlmanHJCamatiniMHolmeJAAirborne urban particles (Milan winter-PM2.5) cause mitotic arrest and cell death: Effects on DNA, mitochondria, AhR binding and spindle organization7131831201110.1016/j.mrfmmm.2011.05.01121645525AbbasIVerdinAEscandeFSaint-GeorgesFCazierFMulliezPCourcotDShiraliPGossetPGarçonGIn vitro short-term exposure to air pollution PM2.5-0.3 induced cell cycle alterations and genetic instability in a human lung cell coculture model147146158201610.1016/j.envres.2016.01.04126874047DengXZhangFWangLRuiWLongFZhaoYChenDDingWAirborne fine particulate matter induces multiple cell death pathways in human lung epithelial cells1910991112201410.1007/s10495-014-0980-524722831DagherZGarconGBilletSGossetPLedouxFCourcotDAboukaisAShiraliPActivation of different pathways of apoptosis by air pollution particulate matter (PM2.5) in human epithelial lung cells (L132) in culture2251224200610.1016/j.tox.2006.04.03816787692EzegbunamWForonjyRPosttranscriptional control of airway inflammation9e1455201810.1002/wrna.1455SuNLinJChenPLiJWuCYinKLiuCChenYZhouXYuanYEvaluation of asthma control and patient's perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China50861870201310.3109/02770903.2013.80834623713625TecerLHAlaghaOKaracaFTuncelGEldesNParticulate matter (PM(2.5), PM(10-2.5), and PM(10)) and children's hospital admissions for asthma and respiratory diseases: A bidirectional case-crossover study71512520200810.1080/1528739080190745918338286JalaludinBKhalajBSheppeardVMorganGAir pollution and ED visits for asthma in Australian children: A case-crossover analysis81967974200810.1007/s00420-007-0290-018094989JacqueminBSirouxVSanchezMCarsinAESchikowskiTAdamMBellisarioVBuschkaABonoRBrunekreefBAmbient air pollution and adult asthma incidence in six European cohorts (ESCAPE)123613621201525712593KimHKimHParkYHLeeJTAssessment of temporal variation for the risk of particulate matters on asthma hospitalization156542550201710.1016/j.envres.2017.04.01228432994YanCWongGWJingLEnvironmental exposure and genetic predisposition as risk factors for Asthma in China892100201610.4168/aair.2016.8.2.9226739401MaestrelliPCanovaCScapellatoMLVisentinATessariRBartolucciGBSimonatoLLottiMPersonal exposure to particulate matter is associated with worse health perception in adult asthma21120128201121462802WagnerJGMorishitaMKeelerGJHarkemaJRDivergent effects of urban particulate air pollution on allergic airway responses in experimental asthma: A comparison of field exposure studies1145201210.1186/1476-069X-11-4522768850XiangZXuXZhengXReponenTChenAXiaHHeavy metals in PM 2.5 and in blood, and children's respiratory symptoms and asthma from an e-waste recycling area210346353201610.1016/j.envpol.2016.01.02526803791YaoWWangCZhongNHanXWuCYanXChenPYangWHenleyMKramerBEffect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: A 26-week Asia-Pacific study19231238201410.1111/resp.1221124383720Montoya-EstradaATorres-RamosYDFlores-PliegoARamirez-VenegasACeballos-ReyesGMGuzman-GrenfellAMHicksJJUrban PM2.5 activates GAPDH and induces RBC damage in COPD patients5638649201310.2741/S39623277075CortezlugoMRamírezaguilarMPérezpadillaRSansoresmartínezRRamírezvenegasABarrazavillarrealAEffect of personal exposure to PM2.5 on respiratory health in a mexican panel of patients with COPD121063510647201510.3390/ijerph12091063526343703RiceMBLjungmanPLWilkerEHDoransKSGoldDRSchwartzJKoutrakisPWashkoGRO'ConnorGTMittlemanMALong-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study191656664201510.1164/rccm.201410-1875OC25590631RenJLiBYuDLiuJMaZApproaches to prevent the patients with chronic airway diseases from exacerbation in the haze weather8E1E7201626904232RahmanIAdcockIOxidative stress and redox regulation of lung inflammation in COPD28219242200610.1183/09031936.06.0005380516816350WattersonTLSorensonJMartinRCoulombeRAJrEffects of PM2.5 Collected from Cache Valley Utah in Human Bronchial Epithelial Cells2006LiRKouXXieLChengFGengHEffects of ambient PM2.5 on pathological injury, inflammation, oxidative stress, metabolic enzyme activity, and expression of c-fos and c-jun in lungs of rats222016720176201510.1007/s11356-015-5222-z26304807RivaDRMagalhãesCBLopesAALançasTMauadTMalmOValençaSSSaldivaPHFaffeDSZinWALow dose of fine particulate matter (PM2.5) can induce acute oxidative stress, inflammation and pulmonary impairment in healthy mice235767201110.3109/08958378.2011.566290ZhaoQJLiuXJZengXLBaoHREffect of PM2.5 on the level of nuclear factor erythroid-2 related factor 2 in chronic obstructive pulmonary disease mice and its relationship with oxidative stress96224122452016(In Chinese)27480657YanZWangJLiJJiangNZhangRYangWYaoWWuWOxidative stress and endocytosis are involved in upregulation of interleukin-8 expression in airway cells exposed to PM2.53118691878201610.1002/tox.2218826303504XuDHuangNWangQLiuHStudy of ambient PM2.5 on the influence of the inflammation injury and the immune function of subchronic exposure rats374234282008(In Chinese)18839524ShuJLiuXChuXQiuJZengXBaoHEffects of PM2.5 on phagocytic function of alveolar macrophages in chronic obstructive pulmonary disease mice963013052016(In Chinese)26879794GuXYChuXZengXLBaoHRLiuXJEffects of PM2.5 exposure on the Notch signaling pathway and immune imbalance in chronic obstructive pulmonary disease226163173201710.1016/j.envpol.2017.03.07028431315HongZGuoZZhangRXuJDongWZhuangGDengCAirborne fine particulate matter induces oxidative stress and inflammation in human nasal epithelial cells239117125201610.1620/tjem.239.11727246665BekkiKItoTYoshidaYHeCArashidaniKHeMSunGZengYSoneHKunugitaNPM2.5 collected in China causes inflammatory and oxidative stress responses in macrophages through the multiple pathways45362369201610.1016/j.etap.2016.06.02227393915LiuQBaumgartnerJZhangYLiuYSunYZhangMOxidative potential and inflammatory impacts of source apportioned ambient air pollution in Beijing481292012929201410.1021/es502987625279798ZhangXZhongWMengQLinQFangCHuangXLiCHuangYTanJAmbient PM2.5 exposure exacerbates severity of allergic asthma in previously sensitized mice52785794201526194420ZhaoCLiaoJChuWWangSYangTTaoYWangGInvolvement of TLR2 and TLR4 and Th1/Th2 shift in inflammatory responses induced by fine ambient particulate matter in mice24918927201210.3109/08958378.2012.73109323121301HuangKLLiuSYChouCCLeeYHChengTJThe effect of size-segregated ambient particulate matter on Th1/Th2-like immune responses in mice12e0173158201710.1371/journal.pone.017315828245275XieXChenJLiFTianJGaoJSZhangDA T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy11155161201110.1007/s10238-010-0123-421161670JassalMSBakmanIJonesBCorrelation of ambient pollution levels and heavily-trafficked roadway proximity on the prevalence of smear-positive tuberculosis127268274201310.1016/j.puhe.2012.12.03023453197LaiTCChiangCYWuCFYangSLLiuDPChanCCLinHHAmbient air pollution and risk of tuberculosis: A cohort study735661201610.1136/oemed-2015-10299526514394NicolaICeruttiFGregoEBertoneIGianellaPD'AngeloAPelettoSBellinoCCharacterization of the upper and lower respiratory tract microbiota in Piedmontese calves5152201710.1186/s40168-017-0372-529157308Rivas-SantiagoCESarkarSCantarellaPIVOsornio-VargasÁQuintana-BelmaresRMengQKirnTJStricklandOhman PChowJCWatsonJGAir pollution particulate matter alters antimycobacterial respiratory epithelium innate immunity8325072517201510.1128/IAI.03018-1425847963MacIntyreEAGehringUMölterAFuertesEKlümperCKrämerUQuassUHoffmannBGasconMBrunekreefBAir pollution and respiratory infections during early childhood: An analysis of 10 European birth cohorts within the ESCAPE Project122107113201424149084DarrowLAKleinMFlandersWDMulhollandJATolbertPEStricklandMJAir pollution and acute respiratory infections among children 0–4 years of age: An 18-year time-series study180968977201410.1093/aje/kwu23425324558GhoshRRossnerPHonkovaKDostalMSramRJHertzpicciottoIAir pollution and childhood bronchitis: Interaction with xenobiotic, immune regulatory and DNA repair genes8794100201610.1016/j.envint.2015.10.00226655675
Function of PM2.5 in the pathogenesis of lung cancer. PM2.5 induces oncogene activation and tumor suppressor gene inactivation through microRNA dysregulation and DNA methylation in lung cancer. Tumor microenvironment alteration is also detected in PM2.5-induced inflammatory cells. PM2.5, particulate matter 2.5.
Function of PM2.5 in the pathogenesis of chronic airway inflammatory diseases. PM2.5 affects normal lung cells in chronic airway inflammatory diseases by affecting cytokine expression and oxidative stress. PM2.5, particulate matter 2.5.